Johnson & Johnson
Founded in 1886, Johnson & Johnson is one of the oldest pharmaceutical companies in the country. Known for developing medical devices, pharmaceuticals, and consumer packaged goods, J&J is home to well-known products including Band-Aid bandages, Tylenol pain medications, Neutrogena skin and body products, and Acuvue contact lenses. Johnson & Johnson maintains operations in 60 countries, while its roughly 250 subsidiaries and their products are sold in more than 175 countries. During the coronavirus pandemic, Johnson & Johnson’s COVID-19 vaccine was the third to receive emergency use authorization from the U.S. Food and Drug Administration. Additionally, J&J’s vaccine was the first to be okayed in the U.S. that required only a single dose, and its administration into the arms of Americans significantly helped the country curb the spread of the virus and get back on a path to normalcy.
Justin Sullivan—Getty Images
Company Information
As of 6/5/23
Country
U.S.
Headquarters
New Brunswick, N.J.
Industry
Pharmaceuticals
CEO
Joaquin Duato
Website
Company Type
Public
Ticker
JNJ
Revenues ($M)
$94,943
Profits ($M)
$17,941
Market Value ($M)
$483,576
Employees
152,700
Market value as of March 31, 2023.
America's Most Innovative Companies
Sector
Health Care
Culture rank
62
Process rank
83
Product rank
14
World's Most Admired Companies
Sector
Natural resources
Industry
Pharmaceuticals
Current All-Star Rank
22
Previous All-Star Rank
17
Industry Rank
1
Previous Industry Rank
1
Overall Score
7.88
Innovation
3
People Management
1
Use of Corporate Assets
1
Social Responsibility
3
Quality of Management
1
Financial Soundness
1
Long-Term Investment Value
1
Quality of Products/Services
4
Global Competitiveness
1
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$93,775
13.6%
Profits ($M)
$20,878
41.9%
Assets ($M)
$182,018
-
Total Stockholder Equity ($M)
$74,023
-
Profit Ratios
Profit as % of Revenues
22.3%
Profits as % of Assets
11.5%
Profits as % of Stockholder Equity
28.2%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
7.81
EPS % Change (from 2020)
41.7%
EPS % Change (5 year annual rate)
5.7%
EPS % Change (10 year annual rate)
8.4%
Total Return
Total Return to Investors (2021)
11.5%
Total Return to Investors (5 year, annualized)
11.1%
Total Return to Investors (10 year, annualized)
13.2%
Lists ranking Johnson & Johnson
Latest news for Johnson & Johnson
- Brainstorm Health 2023 - How Ai Is Advancing Healthcare R&D Today ;18:55Conferences, Brainstorm Health;
- Brainstorm Health 2023 - Dollars and Sense of Health Equity ;19:48Conferences, Brainstorm Health;
- The 2023 World's Most Admired Companies list;1:03Digital Features;
- Brainstorm Tech 2022: Digital Transformation For An Evolving Future;41:19Conferences, Brainstorm Tech;